tiprankstipranks
Kura Oncology (KURA)
NASDAQ:KURA
Holding KURA?
Track your performance easily

Kura Oncology (KURA) Income Statement

553 Followers

Kura Oncology Income Statement

Last quarter (Q3 2024), Kura Oncology's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Kura Oncology's net income was $-54.40M. See Kura Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 217.50M$ 165.80M$ 139.87M$ 131.26M$ 91.90M$ 67.48M
Operating Income
$ -217.50M$ -165.80M$ -139.87M$ -131.26M$ -91.90M$ -67.48M
Net Non Operating Interest Income Expense
$ 20.36M$ 13.17M$ 4.03M$ 792.00K$ 2.27M$ 4.09M
Other Income Expense
---$ 212.00K$ -51.00K$ -245.00K
Pretax Income
$ -197.14M$ -152.63M$ -135.84M$ -130.47M$ -89.63M$ -63.14M
Tax Provision
$ -11.03M$ -11.03M$ -9.72M$ -9.76M$ -7.68M$ -4.81M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -197.55M$ -152.63M$ -135.84M$ -130.47M$ -89.63M$ -63.14M
Basic EPS
$ -2.36$ -2.08$ -2.03$ -1.97$ -1.69$ -1.51
Diluted EPS
$ -2.36$ -2.08$ -2.03$ -1.97$ -1.69$ -1.51
Basic Average Shares
$ 334.97M$ 73.23M$ 66.99M$ 66.35M$ 53.08M$ 41.95M
Diluted Average Shares
$ 334.97M$ 73.23M$ 66.99M$ 66.35M$ 53.08M$ 41.95M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 123.98M$ 165.80M$ 139.87M$ 131.26M$ 91.90M$ 67.48M
Net Income From Continuing And Discontinued Operation
$ -197.55M$ -152.63M$ -135.84M$ -130.47M$ -89.63M$ -63.14M
Normalized Income
$ -103.78M-----
Interest Expense
------
EBIT
$ -153.96M$ -151.08M$ -135.61M$ -130.05M$ -89.05M$ -62.56M
EBITDA
$ -149.79M$ -150.23M$ -134.85M$ -129.49M$ -88.85M$ -63.66M
Currency in USD

Kura Oncology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis